Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Revised Recommendations for the Treatment of Infants Diagnosed with Spinal Muscular Atrophy Via Newborn Screening Who Have 4 Copies of SMN2.

Glascock J, Sampson J, Connolly AM, Darras BT, Day JW, Finkel R, Howell RR, Klinger KW, Kuntz N, Prior T, Shieh PB, Crawford TO, Kerr D, Jarecki J.

J Neuromuscul Dis. 2020;7(2):97-100. doi: 10.3233/JND-190468. No abstract available.

PMID:
32007960
2.

Spinal Muscular Atrophy (SMA) Subtype Concordance in Siblings: Findings From the Cure SMA Cohort.

Jones CC, Cook SF, Jarecki J, Belter L, Reyna SP, Staropoli J, Farwell W, Hobby K.

J Neuromuscul Dis. 2020;7(1):33-40. doi: 10.3233/JND-190399.

3.

Postural disorders in the elderly in static assessment.

Sobiech M, Zawadka M, Kochman M, Jarecki J, Blicharski T, Jabłoński M.

Wiad Lek. 2019;72(9 cz 1):1703-1707.

PMID:
31586987
4.

[Cartilage ageing and treatment possibilities].

Jarecki J.

Wiad Lek. 2019;72(9 cz 1):1671-1675. Review. Polish.

PMID:
31586981
5.

Evaluating Benefit-risk Decision-making in Spinal Muscular Atrophy: A First-ever Study to Assess Risk Tolerance in the SMA Patient Community.

Cruz R, Belter L, Wasnock M, Nazarelli A, Jarecki J.

Clin Ther. 2019 May;41(5):943-960.e4. doi: 10.1016/j.clinthera.2019.03.012. Epub 2019 May 3.

6.

Treatment Algorithm for Infants Diagnosed with Spinal Muscular Atrophy through Newborn Screening.

Glascock J, Sampson J, Haidet-Phillips A, Connolly A, Darras B, Day J, Finkel R, Howell RR, Klinger K, Kuntz N, Prior T, Shieh PB, Crawford TO, Kerr D, Jarecki J.

J Neuromuscul Dis. 2018;5(2):145-158. doi: 10.3233/JND-180304.

7.

An overview of the Cure SMA membership database: Highlights of key demographic and clinical characteristics of SMA members.

Belter L, Cook SF, Crawford TO, Jarecki J, Jones CC, Kissel JT, Schroth M, Hobby K.

J Neuromuscul Dis. 2018;5(2):167-176. doi: 10.3233/JND-170292.

8.

Barriers and facilitators to clinical trial participation among parents of children with pediatric neuromuscular disorders.

Peay HL, Biesecker BB, Wilfond BS, Jarecki J, Umstead KL, Escolar DM, Tibben A.

Clin Trials. 2018 Apr;15(2):139-148. doi: 10.1177/1740774517751118. Epub 2018 Feb 23.

9.

An Evidence-Based, Community-Engaged Approach to Develop an Interactive Deliberation Tool for Pediatric Neuromuscular Trials.

Moultrie RR, Lewis MA, Paquin RS, Lucas A, Jarecki J, Peay HL.

J Genet Couns. 2018 Apr;27(2):416-425. doi: 10.1007/s10897-017-0190-8. Epub 2017 Dec 20.

PMID:
29260486
10.

Naïve and Robust: Class-Conditional Independence in Human Classification Learning.

Jarecki JB, Meder B, Nelson JD.

Cogn Sci. 2018 Jan;42(1):4-42. doi: 10.1111/cogs.12496. Epub 2017 Jun 2.

PMID:
28574602
11.

Cure SMA and our patient community celebrate the first approved drug for SMA.

Glascock J, Lenz M, Hobby K, Jarecki J.

Gene Ther. 2017 Sep;24(9):498-500. doi: 10.1038/gt.2017.39. Epub 2017 May 15. Review.

PMID:
28504658
12.

A qualitative study of perceptions of meaningful change in spinal muscular atrophy.

McGraw S, Qian Y, Henne J, Jarecki J, Hobby K, Yeh WS.

BMC Neurol. 2017 Apr 4;17(1):68. doi: 10.1186/s12883-017-0853-y.

13.

Anaesthesia for carotid endarterectomy. Ultrasound-guided superficial/intermediate cervical plexus block combined with carotid sheath infiltration.

Mądro P, Dąbrowska A, Jarecki J, Garba P.

Anaesthesiol Intensive Ther. 2016;48(4):234-238. doi: 10.5603/AIT.2016.0043.

14.

Understanding the experiences and needs of individuals with Spinal Muscular Atrophy and their parents: a qualitative study.

Qian Y, McGraw S, Henne J, Jarecki J, Hobby K, Yeh WS.

BMC Neurol. 2015 Oct 24;15:217. doi: 10.1186/s12883-015-0473-3.

15.

Assays for the identification and prioritization of drug candidates for spinal muscular atrophy.

Cherry JJ, Kobayashi DT, Lynes MM, Naryshkin NN, Tiziano FD, Zaworski PG, Rubin LL, Jarecki J.

Assay Drug Dev Technol. 2014 Aug;12(6):315-41. doi: 10.1089/adt.2014.587. Review.

16.

Interview with Jill Jarecki, PhD.

Jarecki J, Glaser V.

Assay Drug Dev Technol. 2014 Aug;12(6):311-4. doi: 10.1089/adt.2014.1505. No abstract available.

17.

The DcpS inhibitor RG3039 improves survival, function and motor unit pathologies in two SMA mouse models.

Gogliotti RG, Cardona H, Singh J, Bail S, Emery C, Kuntz N, Jorgensen M, Durens M, Xia B, Barlow C, Heier CR, Plasterer HL, Jacques V, Kiledjian M, Jarecki J, Rusche J, DiDonato CJ.

Hum Mol Genet. 2013 Oct 15;22(20):4084-101. doi: 10.1093/hmg/ddt258. Epub 2013 Jun 4.

18.

Three independent techniques localize expression of transcript afp-11 and its bioactive peptide products to the paired AVK neurons in Ascaris suum: in situ hybridization, immunocytochemistry, and single cell mass spectrometry.

Jarecki JL, Viola IR, Andersen KM, Miller AH, Ramaker MA, Vestling MM, Stretton AO.

ACS Chem Neurosci. 2013 Mar 20;4(3):418-34. doi: 10.1021/cn3001334. Epub 2012 Dec 27.

19.

Kinesin-1 acts with netrin and DCC to maintain sensory neuron position in Caenorhabditis elegans.

Barsi-Rhyne BJ, Miller KM, Vargas CT, Thomas AB, Park J, Bremer M, Jarecki JL, VanHoven MK.

Genetics. 2013 May;194(1):175-87. doi: 10.1534/genetics.113.149310. Epub 2013 Mar 8.

20.

Discovery of neuropeptides in the nematode Ascaris suum by database mining and tandem mass spectrometry.

Jarecki JL, Frey BL, Smith LM, Stretton AO.

J Proteome Res. 2011 Jul 1;10(7):3098-106. doi: 10.1021/pr2001176. Epub 2011 May 27.

21.

A specific antibody to neuropeptide AF1 (KNEFIRFamide) recognizes a small subset of neurons in Ascaris suum: differences from Caenorhabditis elegans.

Sithigorngul P, Jarecki JL, Stretton AO.

J Comp Neurol. 2011 Jun 1;519(8):1546-61. doi: 10.1002/cne.22584.

22.

Mapping neuropeptide expression by mass spectrometry in single dissected identified neurons from the dorsal ganglion of the nematode Ascaris suum.

Jarecki JL, Andersen K, Konop CJ, Knickelbine JJ, Vestling MM, Stretton AO.

ACS Chem Neurosci. 2010 Jul 21;1(7):505-519.

23.

Effects of 2,4-diaminoquinazoline derivatives on SMN expression and phenotype in a mouse model for spinal muscular atrophy.

Butchbach ME, Singh J, Thorsteinsdóttir M, Saieva L, Slominski E, Thurmond J, Andrésson T, Zhang J, Edwards JD, Simard LR, Pellizzoni L, Jarecki J, Burghes AH, Gurney ME.

Hum Mol Genet. 2010 Feb 1;19(3):454-67. doi: 10.1093/hmg/ddp510. Epub 2009 Nov 6.

24.

DcpS as a therapeutic target for spinal muscular atrophy.

Singh J, Salcius M, Liu SW, Staker BL, Mishra R, Thurmond J, Michaud G, Mattoon DR, Printen J, Christensen J, Bjornsson JM, Pollok BA, Kiledjian M, Stewart L, Jarecki J, Gurney ME.

ACS Chem Biol. 2008 Nov 21;3(11):711-22. doi: 10.1021/cb800120t.

25.

Obstructed uterus and kidneys.

Baumann BM, Jarecki J.

J Emerg Med. 2010 May;38(4):497-8. doi: 10.1016/j.jemermed.2007.10.062. Epub 2008 Apr 24. No abstract available.

PMID:
18439795
26.

Posttraumatic delayed facial nerve palsy.

Baumann BM, Jarecki J.

Am J Emerg Med. 2008 Jan;26(1):115.e1-2. No abstract available.

PMID:
18082808
27.

A tetrafluorophenyl activated ester self-assembled monolayer for the immobilization of amine-modified oligonucleotides.

Lockett MR, Phillips MF, Jarecki JL, Peelen D, Smith LM.

Langmuir. 2008 Jan 1;24(1):69-75. Epub 2007 Nov 30.

28.

Diverse small-molecule modulators of SMN expression found by high-throughput compound screening: early leads towards a therapeutic for spinal muscular atrophy.

Jarecki J, Chen X, Bernardino A, Coovert DD, Whitney M, Burghes A, Stack J, Pollok BA.

Hum Mol Genet. 2005 Jul 15;14(14):2003-18. Epub 2005 Jun 8.

PMID:
15944201
29.

Valproic acid increases SMN levels in spinal muscular atrophy patient cells.

Sumner CJ, Huynh TN, Markowitz JA, Perhac JS, Hill B, Coovert DD, Schussler K, Chen X, Jarecki J, Burghes AH, Taylor JP, Fischbeck KH.

Ann Neurol. 2003 Nov;54(5):647-54.

PMID:
14595654
30.

Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients.

Andreassi C, Jarecki J, Zhou J, Coovert DD, Monani UR, Chen X, Whitney M, Pollok B, Zhang M, Androphy E, Burghes AH.

Hum Mol Genet. 2001 Nov 15;10(24):2841-9.

PMID:
11734549
31.

Oxygen regulation of airway branching in Drosophila is mediated by branchless FGF.

Jarecki J, Johnson E, Krasnow MA.

Cell. 1999 Oct 15;99(2):211-20.

32.

Role of neural activity during synaptogenesis in Drosophila.

Jarecki J, Keshishian H.

J Neurosci. 1995 Dec;15(12):8177-90.

33.

Precision and plasticity during Drosophila neuromuscular development.

Keshishian H, Chang TN, Jarecki J.

FASEB J. 1994 Jul;8(10):731-7. Review.

PMID:
8050672
34.

Cellular mechanisms governing synaptic development in Drosophila melanogaster.

Keshishian H, Chiba A, Chang TN, Halfon MS, Harkins EW, Jarecki J, Wang L, Anderson M, Cash S, Halpern ME, et al.

J Neurobiol. 1993 Jun;24(6):757-87. Erratum in: J Neurobiol 1993 Aug;24(8):1130.

PMID:
8251016
35.

Effects of thematic structure on syntactic comprehension in aphasia.

Cannito MP, Jarecki JM, Pierce RS.

Brain Lang. 1986 Jan;27(1):38-49.

PMID:
2418909

Supplemental Content

Loading ...
Support Center